Krajina: Arménsko
Jazyk: angličtina
Zdroj: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
azelastine (azelastine hydrochloride)
MEDA Pharma GmbH & Co. KG
R01AC03
azelastine (azelastine hydrochloride)
1mg/1ml
spray nasal
10ml glass vial with pump dispenser
OTC
Registered
2016-12-09
SUMMARY OF PRODUCT CHARACTERISTICS / SPC ALLERGODIL® NASAL SPRAY LAST REVISED: SEPTEMBER 2010 _Translation from the German Language _ 1. TRADE NAME OF THE MEDICINAL PRODUCT Allergodil ® Nasal Spray 1 mg / 1 ml Active substance: Azelastine hydrochloride 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 spray puff (0.14 ml) contains: 0.14 mg of Azelastine hydrochloride 3. PHARMACEUTICAL FORM Nasal spray, Solution 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Allergodil Nasal Spray is an anti-allergic agent / antihistaminic agent. For symptomatic treatment of seasonal allergic rhinitis (hay fever) and for symptomatic treatment of non-seasonal (perennial) allergic rhinitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION To be sprayed into the nose; for nasal application. Unless otherwise prescribed, spray Allergodil Nasal Spray once into each nostril twice daily (mornings and evenings; equivalent to a daily dose of 0.56 mg Azelastine hydrochloride / day). Spray the solution into each nostril with head held upright. Duration of treatment depends on the type, severity and the development of the symptoms. Allergodil Nasal Spray may be used for long-term treatment; Should not be used continuously for more than 6 months. 4.3 CONTRA-INDICATIONS - Hypersensitivity to azelastine and / or other components of the formulation. - If allergic rhinitis and rhinoconjunctivitis - Children up to age 6 years. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE In some cases, the use of a nasal spray detected fatigue varying severity and weakness, which may be caused and also the basic condition. In these cases, it is not recommended to drive a car and work with dangerous machinery. Drinking alcohol may intensify these effects. 4.5 INTERACTIONS WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION So far, no interactions have been reported. 4.6 PREGNANCY AND LACTATION Although doses far in excess of the therapeutic dose range tested in laboratory animals failed to generate any evidence of an embryotoxic effect of this medicinal product, curren Prečítajte si celý dokument